Notebook

STICKING POINT: Zebra mussels, here attached to a crayfish, can be real pests. Late last month President Bill Clinton signed the National Invasive Species Act, which will provide additional funds to combat a growing ecological and economic problem. Non-native freshwater and marine plants and animals from as far away as Asia are carried to North American estuaries like San Francisco Bay-where they sometimes gain a troublesome toehold-in ship ballast water. The act authorizes an average of $22

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

STICKING POINT: Zebra mussels, here attached to a crayfish, can be real pests. Late last month President Bill Clinton signed the National Invasive Species Act, which will provide additional funds to combat a growing ecological and economic problem. Non-native freshwater and marine plants and animals from as far away as Asia are carried to North American estuaries like San Francisco Bay-where they sometimes gain a troublesome toehold-in ship ballast water. The act authorizes an average of $22.4 million for research and monitoring annually over the next six years, notes Bob Peoples, the non-indigenous species coordinator for the United States Fish and Wildlife Service. He notes that the agency is still working out details regarding how and when to make the funds available to researchers. Waterborne creatures are flushed into the surrounding water when ships wash out their ballast holds. Some of the foreign species thrive in their new home so ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies